Develops gene-editing medicines using the CRISPR/Cas9 platform.
| Title |
|---|
| Senior Manager, Alliance Management Full Time · $150K-$165K · 6+ YOE South Boston, Massachusetts, United States · Onsite |
| Clinical Trial Associate (6-Month Contract) Full Time · $83K-$104K/yr · 2+ YOE South Boston, Massachusetts, United States · Onsite |
| Senior Specialist, Site Supply Chain Planning Full Time · $110K-$120K · 7+ YOE Framingham, Massachusetts, United States · Onsite |
| Manager, Clinical Data Management Full Time · $123K-$133K · 7+ YOE South Boston, Massachusetts, United States · Onsite |
| Scientist II, Computational Biology & AI Full Time · $140K-$150K · 2+ YOE South Boston, Massachusetts, United States · Onsite |
| Senior Clinical Scientist Full Time · $140K-$160K · 4+ YOE Boston, Massachusetts, United States · Onsite |
| Senior Scientist, LNP MSAT Full Time · $137K-$150K · 5+ YOE Boston, Massachusetts, United States · Onsite |
| Executive Director, External Manufacturing & Supply Chain Full Time · 15+ YOE South Boston, Massachusetts, United States · Onsite |
| Activities | Gene editing researchTherapeutic candidate developmentClinical trial executionBiotechnology manufacturingBiopharmaceutical strategic partnerships |
| Headquarters | CH |
| Industries | BiotechnologyPharmaceuticals |
| Name | CRISPR Therapeutics |
| Employees | 393 |
| Type | Public |
| Subsidiaries | CRISPR Therapeutics, Inc.Casebia Therapeutics |
| Tagline | Develops gene-editing medicines using the CRISPR/Cas9 platform. |
| Founded | 2,013 |
| Website | crisprtx.com |
| Stock Exchange | NASDAQ |
| Stock Symbol | CRSP |